Atlas Trials

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Clinical trial NCT06020066 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06020066
Sponsor
Fudan University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasesNon-small Cell Lung Cancer
Start date
2023-08-10
Primary completion
2027-08-10
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.